Automated machine learning is explored to predict the 2-year mortality for astrocytic brain tumour patients by taking into account proteasomal functional parameters.
For secondary analysis of CRASH-3 RCT, automated machine learning is explored to predict in-hospital mortality among acute traumatic brain injury patients randomly assigned to Tranexamic acid management.